The emergence of a new class of antibiotics by Kinvard Bio marks a pivotal moment in the ongoing battle against drug-resistant bacteria.With antimicrobial resistance on the rise, traditional antibiotics increasingly fail to combat stubborn infections, leading to a global health crisis that resulted in more than a million deaths in recent years.